A Study to Evaluate the Efficacy, and Safety Study of Ruxolitinib Cream in Adults With Moderate Atopic Dermatitis
Clinical trial NCT06238817 · COMPLETED
Trial details
- NCT number
- NCT06238817
- Sponsor
- Incyte Corporation
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-04-26
- Primary completion
- 2025-05-21
- Enrollment
- 241
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.